Antibiotic Therapy and Offstage about Covid-19 Vaccination
- 1 Biochemistry Department, Azerbaijan Medical University, Baku, Azerbaijan
- 2 “Kepro” Clinics, Baku, Azerbaijan
- 3 Health Sciences Department, City University College of Ajman, Ajman, UAE
- 4 Family Medicine Department, Azerbaijan Medical University, Baku, Azerbaijan
- 5 Prosthodontic Department, College of Dentistry Ajman University of Science and Technology, Ajman, UAE
- 6 Biochemistry Department, Azerbaijan Medical University, Baku, Azerbaijan
- 7 Health Sciences Department, City University College of Ajman, Ajman, UAE
- 8 Health Sciences Department, City University College of Ajman, Ajman, UAE
Abstract
In this overview, we discuss the impact of antibiotic therapy on the COVID infection, the complications after vaccination, possible causes of adverse events, and ways to protect against pandemic infection, as well as try to dispel myths about COVID. Antibiotics are necessary only in case of secondary infection, but overlapping with bacterial infection mainly occurs after hospitalization, and the vast majority of infections were caused by the Acinetobacter baumannii strain. Commonly used antimicrobial disinfectants are chlorhexidine derivatives; due to their frequent use, microorganisms have become resistant to them, and in addition, chloroquine has no clinical benefit in the treatment of COVID-19. Virus escapes from the immune response due to multiple mutations in the receptor-binding domain, or the N-terminal end, which are the sites responsible for antibody binding and virus neutralization. The COVID infection itself is characterized by a rather powerful suppression of immunity. For this reason, the use of antibiotics in the absence of a secondary infection layer leads to greater suppression of the immune system and an aggravation of the process, which often ends up fatally. Immune dysregulation predisposes to the development of severe COVID-19. A decrease in the number of leukocytes gives an unfavorable prognosis for the severity of the COVID infection course. The main reason for the death cases after vaccination seems to be an increase in blood clotting, which is observed not only among the population over 60 years old, but also amid young people.
- Chen, N., Zhou, M., Dong, X., et al. (2020) Epidemiological and Clinical Characteristics of 99 Cases of 2019 Novel Coronavirus Pneumonia in Wuhan, China: A Descriptive Study. The Lancet, 395, 507-513. https://doi.org/10.1016/S0140-6736(20)30211-7
- Cordon, G. and Powell, L. (2021) Free Twice-Weekly COVID Tests to Be Offered to Everyone in England. Medscape News UK.
- Menni, C., Valdes, A.M., Freidin, M.B., et al. (2020) Real-time tracking of Self-Reported Symptoms to Predict Potential COVID-19. Nature Medicine, 26, 1037-1040. https://doi.org/10.1038/s41591-020-0916-2
- Tucker, M.E. (2021) COVID-19 ‘Long-Haul’ Symptoms Overlap With ME/CFS. Medscape Medical News, March 26.
- World Health Organization (2022) Advice for public/mythbusters. https://www.who.int/emergencies/diseases/novel-coronavirus-2019
- Estrada, A.D., Parra, J.C., Carracedo, E.F., et al. (2021) Inadequate Use of Antibiotics in the Covid-19 Era: Effectiveness of Antibiotic Therapy. BioMed Central Infectious Diseases, 21, Article No. 1144. https://doi.org/10.1186/s12879-021-06821-1
- Mahoney, A.R., Safaee, M.M., Wuest, W.M. and Furst, A. (2021) The Silent Pandemic: Emergent Antibiotic Resistances Following the Global Response to SARS-CoV-2. iScience, 24, Article ID: 102304. https://doi.org/10.1016/j.isci.2021.102304
- Wang, C., Wang, Z., Wang, G., et al. (2021) COVID-19 in Early 2021: Current Status and Looking Forward. Signal Transduction and Targeted Therapy, 6, Article No. 114. https://doi.org/10.1038/s41392-021-00527-1
- Zheng, X., Wang, H., Su, Z.Y., Li, W., Yang, D.L., Deng, F. and Chen, J.J. (2020) Co-infection of SARS-CoV-2 and Influenza virus in Early Stage of the COVID-19 Epidemic in Wuhan, China. Journal of Infection, 81, 128-129. https://doi.org/10.1016/j.jinf.2020.05.041
- Blasco, M.L., Buesa, J., Forner, M.J., Galindo, M.J., Navarro, J., Noceda, J., Redón, J., Signes-Costa, J. and Navarro, D. (2020) Co-Detection of Respiratory Pathogens in Patients Hospitalized with Coronavirus Viral Disease-2019 Pneumonia. Journal of Medical Virology, 92, 1799-1801. https://doi.org/10.1002/jmv.25922
- Wang, P., Nair, M.S., Liu, L., et al. (2021) Antibody Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7. Nature, 593, 130-135. https://doi.org/10.1038/s41586-021-03398-2
- Yu, J., Chai, P.W., Ge, S.H. and Fan, X.Q. (2020) Recent Understandings Toward Coronavirus Disease 2019 (COVID-19): From Bench to Bedside. Frontiers in Cell and Developmental Biology, 8, Article No. 476. https://doi.org/10.3389/fcell.2020.00476